Frankfurt/Moscow | Reuters — Bayer has taken Russia’s competition regulator to court over the watchdog’s investigation into the company’s planned takeover of Monsanto, a further hiccup in the US$64 billion deal amid intense antitrust scrutiny. A Bayer spokesman said the German company was petitioning the court in Russia to be given more time to discuss […] Read more

Bayer petitions Russian antitrust watchdog for more time in Monsanto case

Bayer offers asset sales for EU approval of Monsanto deal
Brussels/Frankfurt | Reuters — Bayer has offered to sell seeds and pesticides businesses to try to address EU competition concerns over its US$63.5 billion bid for U.S. rival Monsanto. The proposed remedies “are very significant and we are confident they fully address the European Commission’s concerns,” the German company said in a statement on Monday. […] Read more

EU review of Bayer’s Monsanto bid postponed further
Frankfurt/Brussels | Reuters — Bayer’s quest to win regulatory approval for its planned takeover of Monsanto ran into further delays on Monday as European Union antitrust investigators extended their investigation by five working days until March 12. The ongoing proceedings would have given the German drugs and pesticides maker until midnight on Monday to offer […] Read more

Bayer says needs more time for Monsanto deal approval
Monheim, Germany | Reuters — German drugs and pesticides group Bayer said Tuesday it was now likely to be early next year before it can complete its US$66 billion deal to acquire U.S. group Monsanto, later than previously expected. The European Commission has been scrutinizing the proposed takeover with a deadline of Jan. 8 but […] Read more

EU starts in-depth probe of Bayer-Monsanto deal
Brussels/Frankfurt | Reuters — The European Commission has started an in-depth investigation of Bayer’s planned US$66 billion takeover of U.S. seeds group Monsanto, saying it was worried about competition in various pesticide and seeds markets. The deal would create the world’s largest integrated pesticides and seeds company, the Commission said, adding this limited the number […] Read more

BASF ready to snatch seed bargains as rivals sell assets
Ludwigshafen, Germany | Reuters — BASF will consider buying seed assets that rivals are putting on the block to win antitrust approval for tie-ups, saying bargain prices could persuade BASF to overcome its traditional reluctance to expand into the seeds industry. Sources familiar with BASF’s thinking have said that competition regulators looking at potential buyers […] Read more

Bayer sees pesticide profits stagnating before Monsanto takeover
Leverkusen, Germany | Reuters — German drugs and pesticides maker Bayer forecast a year without earnings growth for its agricultural products business on Wednesday, as it seeks to complete its US$66 billion deal to take over U.S. seeds giant Monsanto. Bayer has said the deal, which would put the size of its agricultural business on […] Read more

Syngenta sees ChemChina deal closing in second quarter
Reuters — Swiss pesticides and seeds group Syngenta pushed back the expected closure of its agreed US$43 billion takeover by ChemChina to the second quarter of 2017, but said it was making progress in winning regulatory approval for the deal. The transaction is important for China, the world’s largest agricultural market, which is looking to […] Read more

Bayer betting billions farmers will back linked-up supplies
Frankfurt | Reuters — Bayer’s US$66 billion purchase of Monsanto amounts to a long-term bet that farmers will grow to trust combinations of seeds and pesticides rather than continue to pick from ranges of separate products. In the short term, the German drugs and chemicals firm hopes to benefit from a marketing and sales force […] Read more

Bayer clinches Monsanto with raised US$66 billion bid
New York/Frankfurt | Reuters — German drugs and crop chemicals company Bayer has won over U.S. seeds firm Monsanto with an improved takeover offer of US$66 billion including debt, ending months of wrangling after increasing its bid for a third time. The $128 a share deal announced on Wednesday, up from Bayer’s previous offer of […] Read more